Discontinuation report METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION

Last updated on 2021-09-23 History
Report ID 146061
Drug Identification Number 02231893
Brand name METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION
Common or Proper name METHYLPREDNISOLONE SOD SUCC 40MG
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) METHYLPREDNISOLONE
Strength(s) 40MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-09-10
Remaining supply date 2021-09-10
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-09-23 French Compare
v1 2021-09-23 English Compare